company background image
FLRY3 logo

Fleury BOVESPA:FLRY3 Voorraadrapport

Laatste prijs

R$14.55

Marktkapitalisatie

R$7.8b

7D

-4.0%

1Y

-8.8%

Bijgewerkt

04 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

Fleury S.A.

BOVESPA:FLRY3 Voorraadrapport

Marktkapitalisatie: R$7.8b

FLRY3 Overzicht aandelen

Fleury S.A. biedt samen met haar dochterondernemingen medische diensten aan op het gebied van diagnostiek, behandeling, klinische analyse, gezondheidsmanagement, medische zorg, orthopedie en oogheelkunde in Brazilië.

Over het bedrijf

FLRY3 fundamentele analyse
Sneeuwvlok Score
Waardering5/6
Toekomstige groei2/6
Prestaties in het verleden5/6
Financiële gezondheid4/6
Dividenden4/6

Beloningen

Verhandeld tegen 32.7% onder onze schatting van de reële waarde
De winst zal naar verwachting met 13.93% per jaar groeien
De winst groeide het afgelopen jaar met 102.2%
Analisten zijn het erover eens dat de aandelenkoers met 31.2% zal stijgen

Risicoanalyse

Onstabiel dividend track record

Fleury S.A. Concurrenten

Oncoclínicas do Brasil Serviços Médicos

BOVESPA:ONCO3

R$2.8b

Odontoprev

BOVESPA:ODPV3

R$6.0b

Rede D'Or São Luiz

BOVESPA:RDOR3

R$64.6b

Profarma Distribuidora de Produtos Farmacêuticos

BOVESPA:PFRM3

R$852.1m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Fleury
Historische aandelenkoersen
Huidige aandelenkoersR$14.55
52 Week HoogtepuntR$18.96
52 Week LaagR$13.69
Bèta0.59
11 maand verandering-3.96%
3 maanden verandering-3.90%
1 Jaar Verandering-8.78%
33 jaar verandering-25.37%
5 jaar verandering-41.42%
Verandering sinds IPO67.42%

Recent nieuws en updates

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Nov 02
Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

Sep 26
Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

Jun 18
We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

Recent updates

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Nov 02
Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

Sep 26
Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

Jun 18
We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

The Price Is Right For Fleury S.A. (BVMF:FLRY3)

Apr 16
The Price Is Right For Fleury S.A. (BVMF:FLRY3)

Concerns Surrounding Fleury's (BVMF:FLRY3) Performance

Mar 14
Concerns Surrounding Fleury's (BVMF:FLRY3) Performance

Earnings Tell The Story For Fleury S.A. (BVMF:FLRY3)

Jan 05
Earnings Tell The Story For Fleury S.A. (BVMF:FLRY3)

Fleury (BVMF:FLRY3) Has A Pretty Healthy Balance Sheet

Oct 05
Fleury (BVMF:FLRY3) Has A Pretty Healthy Balance Sheet

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Jun 27
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

Feb 25
We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

At R$18.27, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Sep 26
At R$18.27, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Sep 08
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Fleury (BVMF:FLRY3) Has Some Way To Go To Become A Multi-Bagger

Jul 01
Fleury (BVMF:FLRY3) Has Some Way To Go To Become A Multi-Bagger

When Should You Buy Fleury S.A. (BVMF:FLRY3)?

Jun 10
When Should You Buy Fleury S.A. (BVMF:FLRY3)?

Is Fleury (BVMF:FLRY3) Using Too Much Debt?

Apr 10
Is Fleury (BVMF:FLRY3) Using Too Much Debt?

Return Trends At Fleury (BVMF:FLRY3) Aren't Appealing

Mar 24
Return Trends At Fleury (BVMF:FLRY3) Aren't Appealing

At R$19.12, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Feb 08
At R$19.12, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Returns On Capital Are Showing Encouraging Signs At Fleury (BVMF:FLRY3)

Dec 08
Returns On Capital Are Showing Encouraging Signs At Fleury (BVMF:FLRY3)

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Nov 05
Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Is Fleury S.A. (BVMF:FLRY3) Potentially Undervalued?

Oct 21
Is Fleury S.A. (BVMF:FLRY3) Potentially Undervalued?

Investors Should Be Encouraged By Fleury's (BVMF:FLRY3) Returns On Capital

Aug 24
Investors Should Be Encouraged By Fleury's (BVMF:FLRY3) Returns On Capital

Fleury (BVMF:FLRY3) Seems To Use Debt Rather Sparingly

Jul 31
Fleury (BVMF:FLRY3) Seems To Use Debt Rather Sparingly

Is It Time To Consider Buying Fleury S.A. (BVMF:FLRY3)?

Jul 07
Is It Time To Consider Buying Fleury S.A. (BVMF:FLRY3)?

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Apr 30
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Fleury (BVMF:FLRY3) Shareholders Will Want The ROCE Trajectory To Continue

Apr 12
Fleury (BVMF:FLRY3) Shareholders Will Want The ROCE Trajectory To Continue

At R$25.16, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Mar 29
At R$25.16, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Should You Or Shouldn't You: A Dividend Analysis on Fleury S.A. (BVMF:FLRY3)

Mar 16
Should You Or Shouldn't You: A Dividend Analysis on Fleury S.A. (BVMF:FLRY3)

Only One Day Left To Cash In On Fleury's (BVMF:FLRY3) Dividend

Mar 01
Only One Day Left To Cash In On Fleury's (BVMF:FLRY3) Dividend

Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Feb 28
Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

What Type Of Shareholders Make Up Fleury S.A.'s (BVMF:FLRY3) Share Registry?

Feb 15
What Type Of Shareholders Make Up Fleury S.A.'s (BVMF:FLRY3) Share Registry?

Shareholders of Fleury (BVMF:FLRY3) Must Be Delighted With Their 360% Total Return

Feb 02
Shareholders of Fleury (BVMF:FLRY3) Must Be Delighted With Their 360% Total Return

Three Days Left To Buy Fleury S.A. (BVMF:FLRY3) Before The Ex-Dividend Date

Jan 03
Three Days Left To Buy Fleury S.A. (BVMF:FLRY3) Before The Ex-Dividend Date

Should We Be Excited About The Trends Of Returns At Fleury (BVMF:FLRY3)?

Dec 28
Should We Be Excited About The Trends Of Returns At Fleury (BVMF:FLRY3)?

Would Fleury S.A. (BVMF:FLRY3) Be Valuable To Income Investors?

Dec 12
Would Fleury S.A. (BVMF:FLRY3) Be Valuable To Income Investors?

Taking A Look At Fleury S.A.'s (BVMF:FLRY3) ROE

Nov 29
Taking A Look At Fleury S.A.'s (BVMF:FLRY3) ROE

Getting In Cheap On Fleury S.A. (BVMF:FLRY3) Might Be Difficult

Aug 30
Getting In Cheap On Fleury S.A. (BVMF:FLRY3) Might Be Difficult

Here's What You Should Know About Fleury S.A.'s (BVMF:FLRY3) 3.8% Dividend Yield

Aug 18
Here's What You Should Know About Fleury S.A.'s (BVMF:FLRY3) 3.8% Dividend Yield

Can Fleury S.A. (BVMF:FLRY3) Improve Its Returns?

Aug 03
Can Fleury S.A. (BVMF:FLRY3) Improve Its Returns?

Could The Fleury S.A. (BVMF:FLRY3) Ownership Structure Tell Us Something Useful?

Jul 22
Could The Fleury S.A. (BVMF:FLRY3) Ownership Structure Tell Us Something Useful?

Is Now The Time To Look At Buying Fleury S.A. (BVMF:FLRY3)?

Jul 10
Is Now The Time To Look At Buying Fleury S.A. (BVMF:FLRY3)?

Rendement voor aandeelhouders

FLRY3BR HealthcareBR Markt
7D-4.0%-3.3%-1.9%
1Y-8.8%-8.8%3.3%

Rendement versus industrie: FLRY3 kwam overeen met de BR Healthcare industrie, die het afgelopen jaar een rendement opleverde van -8.8 %.

Rendement versus markt: FLRY3 presteerde slechter dan BR Market, dat het afgelopen jaar een rendement van 3.3 % opleverde.

Prijsvolatiliteit

Is FLRY3's price volatile compared to industry and market?
FLRY3 volatility
FLRY3 Average Weekly Movement2.8%
Healthcare Industry Average Movement6.4%
Market Average Movement4.4%
10% most volatile stocks in BR Market8.9%
10% least volatile stocks in BR Market2.3%

Stabiele aandelenkoers: FLRY3 heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van FLRY3 is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
192627,000Jeane Tsutsuiri.fleury.com.br

Fleury S.A. biedt samen met haar dochterondernemingen medische diensten aan op het gebied van diagnostiek, behandeling, klinische analyse, gezondheidsmanagement, medische zorg, orthopedie en oogheelkunde in Brazilië. Het bedrijf is actief in drie segmenten: Diagnostische Geneeskunde, Geïntegreerde Geneeskunde en Tandheelkunde. Het biedt laboratorium- en beeldvormingstests, genomica, gezondheidsbeheer en -platform, diagnostische informatie, controle- en referentielaboratorium, kliniekdag, infuuscentrum, orthopedie en oogheelkunde, tandheelkundige beeldvormingstests en diagnostische beeldvormingsdiensten.

Fleury S.A. Samenvatting

Hoe verhouden de winst en inkomsten van Fleury zich tot de beurswaarde?
FLRY3 fundamentele statistieken
MarktkapitalisatieR$7.77b
Inkomsten(TTM)R$597.02m
Inkomsten(TTM)R$7.46b

13.3x

Koers/Winstverhouding

1.1x

P/S-verhouding

Is FLRY3 overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
FLRY3 resultatenrekening (TTM)
InkomstenR$7.46b
Kosten van inkomstenR$5.40b
BrutowinstR$2.06b
Overige uitgavenR$1.46b
InkomstenR$597.02m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

Nov 07, 2024

Winst per aandeel (EPS)1.09
Brutomarge27.63%
Nettowinstmarge8.01%
Schuld/Eigen Vermogen Verhouding70.2%

Hoe presteerde FLRY3 op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

4.0%

Huidig dividendrendement

38%

Uitbetalingsratio